Frank Arguello
Director @ Atavistic Chemotherapy Clinical Trial | James P. Wilmot Fellow
- Role
- Director at Atavistic Chemotherapy Clinical Trial
- Location
- Washington, DC, US
- LinkedIn followers
- 500 followers
About Frank Arguello
I am Dr. Frank Arguello, a director at Atavistic Chemotherapy Clinical Trial, a company that develops and tests a new and effective drug-based approach to treat inoperable and metastatic cancer. I have been working in this field for over 12 years, and I have a strong background in pediatrics hematology and oncology, as well as a fellowship from the University of Rochester School of Medicine and Dentistry.My mission is to change the practice of oncology all over the world by applying the concept of atavism, which explains cancer as a change determined by basic principles of cell survival and evolution that have governed cellular life on Earth for millions of years. I have published a book and multiple articles on this topic, and I have partnered with leading researchers and institutions to conduct clinical trials and demonstrate the efficacy and safety of atavistic chemotherapy. I am passionate about finding a humane and logical solution for the most common and devastating forms of cancer.
Experience
Director
Atavistic Chemotherapy Clinical Trial
Jul 2011 — Present · Frederick, MD, US
Education
College of Bachelors, Torreon, Coah., Mexico.
Bachelor's Degree
1974 — 1978
University of Rochester School of Medicine and Dentistry
James P. Wilmot Fellowship
1987 — 1989
University of Nuevo Leon School of Medicine, Monterrey, N.L., Mexico.
Doctor of Medicine (M.D.)
1978 — 1984
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.